Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Cancer Pain × Infusions, Intravenous × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Cancer Pain 1 Breakthrough Pain 1

Interventions

resiniferatoxin 1 Standard of Care 1 Passive Cutaneous Anaphylaxis 1 Morphine 1 Methadone 1 Infusions, Intravenous 1 Administration, Sublingual 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05053308 2023-08-07

Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement

Seoul National University

Phase NA Withdrawn

Cancer Pain, Breakthrough Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡